AHSC seminar: New technology to treat Parkinson’s and multiple sclerosis
Scientists at Imperial College London and clinicians from Imperial College Healthcare NHS Trust are working together to develop translational research in neuroscience that is internationally recognised and leads to better patient outcomes.
At the next AHSC seminar on 16 July, an expert from the Trust will pair up with an academic from the College to talk about their latest work in neurological diseases.
Dr Nir Grossman, assistant professor at the Division of Brain Sciences at the College, and Professor Paul Matthews, Edmond and Lily Safra Chair of Translational Neuroscience and Therapeutics at the Trust, will talk about their research developing new technologies to improve clinical management for multiple sclerosis and Parkinson’s.
Dr Grossman will talk about his work on developing a non-invasive technique to deep brain simulation. Deep Brain Stimulation (DBS) currently involves cutting open a person’s skull and inserting electrodes inside the brain to reduce physical symptoms, such as shaking. It is often the last option for people such as those with Parkinson’s disease who have very serious symptoms that cannot be controlled through medication alone.
Professor Matthews will discuss his work with wearable sensor technology to assess gait in progressive multiple sclerosis (MS) patients quantitatively in their home environments.
MS is a condition that affects the brain and spinal cord, causing a wide range of potential symptoms, including problems with movement and balance. In progressive MS, symptoms get gradually worse with no remission and there is no treatment that can slow or stop the accumulation of disability.
Lunch will be provided after the presentations.
Find out more and book your place on the seminar's Eventbrite page.